Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Uncover which credit card rewards program is best for your lifestyle. Compare various options to maximize your rewards potential.
23,688 articlesAxsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Oklo edges toward its first commercial nuclear power with government negotiations and a European funding alliance, ex...
Analysts warn that social security faces insolvency by 2032, threatening to reduce guaranteed benefits for 70 million...
As Rocket Lab broadens beyond launches into aerospace and defense, a renewed thesis supports a potential growth path ...
Poet Technologies faces a pivotal year as AI-driven optical interconnects scale. This report analyzes catalysts, risk...
A looming funding cliff could shrink benefits for millions. This guide breaks down the numbers, the political dynamic...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
The latest Trustees report reveals a $160.2 billion gap for 2025, forcing reserve use and signaling looming benefit p...
Rocket Lab’s stock slides after another delay to the Neutron rocket, dimming the year’s record narrative. Investors p...
A 54-year-old former corporate worker considers a welding certificate in shipbuilding after a layoff. The move could ...